ClinicalTrials.Veeva

Menu

EMPHYSEMA AND FLNA MUTATION (E-FNLA)

U

University Hospital, Lille

Status

Completed

Conditions

Emphysema

Treatments

Genetic: blood analysis
Radiation: Chest HRCT
Other: Lung function tests

Study type

Observational

Funder types

Other

Identifiers

NCT05550844
2022-A00972-41 (Other Identifier)
2021_0511

Details and patient eligibility

About

Some sparse scientific data support the hypothesis that otherwise unexplained emphysema may be associated with FLNA mutation. This prospective, monocentric, cross-sectional study aimed to describe the frequency of emphysema in patients carrying an FLNA mutation. Patients with FLNA mutations who accept the study will benefit from a chest physician's clinical examination, respiratory function tests and a chest scan. The primary endpoint is to describe emphysema's frequency in patients carrying FLNA mutation. The other objectives are to describe emphysema's features in these patients and to describe their lung function abnormalities. The final goal is to confirm the association between unexplained emphysema and FLNA mutation.

Enrollment

8 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with an FLNA mutation (or gene alteration)
  • patient who has given written consent to participate in the trial
  • socially insured patient
  • patient willing to comply with all study procedures and duration

Exclusion criteria

  • Patient refused or unable to give informed consent
  • Administrative reasons: inability to receive information, inability to participate in the entire study, lack of coverage by the social security system,
  • Pregnant or breastfeeding women
  • Patient under guardianship
  • Persons deprived of liberty

Trial contacts and locations

1

Loading...

Central trial contact

Cécile Chenivesse, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems